CY1580A - Recombinant dna molecules and their method of production - Google Patents
Recombinant dna molecules and their method of productionInfo
- Publication number
- CY1580A CY1580A CY1580A CY158092A CY1580A CY 1580 A CY1580 A CY 1580A CY 1580 A CY1580 A CY 1580A CY 158092 A CY158092 A CY 158092A CY 1580 A CY1580 A CY 1580A
- Authority
- CY
- Cyprus
- Prior art keywords
- production
- recombinant dna
- dna molecules
- molecules
- recombinant
- Prior art date
Links
- 108020004511 Recombinant DNA Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7849907 | 1978-12-22 | ||
| GB7850039 | 1978-12-27 | ||
| GB7937910 | 1979-11-01 | ||
| EP79303017A EP0013828B2 (de) | 1978-12-22 | 1979-12-21 | Rekombinante DNA, damit transformierte Wirtsorganismen und Verfahren zur Herstellung von Polypeptiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1580A true CY1580A (en) | 1992-04-03 |
Family
ID=27440205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY1580A CY1580A (en) | 1978-12-22 | 1992-04-03 | Recombinant dna molecules and their method of production |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0182442B2 (de) |
| CY (1) | CY1580A (de) |
| KE (1) | KE3747A (de) |
| NL (1) | NL930010I2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2061500T5 (es) * | 1986-06-17 | 2003-05-16 | Chiron Corp | Diagnosis y vacunas de la hepatitis delta, su preparacion y uso. |
| JPH089637B2 (ja) * | 1986-06-18 | 1996-01-31 | 財団法人阪大微生物病研究会 | B型肝炎ウイルス抗原とその製造法 |
| US5348741A (en) * | 1987-02-03 | 1994-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | Vector for recombinant poxvirus expressing rabies virus glycoprotein |
| NZ219515A (en) | 1987-02-10 | 1989-09-27 | Wellcome Found | Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope |
| EP0300213A1 (de) * | 1987-06-22 | 1989-01-25 | Hexal-Pharma Gentechnik GmbH & Co. KG | Virale, immunogen wirksame Peptidpartikel von Hepatitis A |
| EP0491077A1 (de) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten |
| JP3026029B2 (ja) * | 1991-04-26 | 2000-03-27 | 財団法人阪大微生物病研究会 | 組換え水痘ウイルスとその作製法 |
| US5175094A (en) * | 1991-08-01 | 1992-12-29 | Becton Dickinson And Company | Increased expression of HBcAg |
| US5173427A (en) * | 1991-08-01 | 1992-12-22 | Becton Dickinson And Company | Vectors and hosts with increased expression of HBCAG |
| US5175272A (en) * | 1991-08-01 | 1992-12-29 | Becton Dickinson And Company | DNA sequences with increased expression of HBcAg |
| GB9706957D0 (en) | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
| GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
| GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2444713A1 (fr) * | 1978-12-18 | 1980-07-18 | Pasteur Institut | Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant |
| FR2480779B2 (fr) * | 1979-08-30 | 1986-07-18 | Anvar | Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur |
| IE52036B1 (en) * | 1979-05-24 | 1987-05-27 | Univ California | Non-passageable viruses |
-
1979
- 1979-12-21 EP EP85201908A patent/EP0182442B2/de not_active Expired - Lifetime
-
1987
- 1987-08-14 KE KE3747A patent/KE3747A/xx unknown
-
1992
- 1992-04-03 CY CY1580A patent/CY1580A/xx unknown
-
1993
- 1993-02-17 NL NL930010C patent/NL930010I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0182442A2 (de) | 1986-05-28 |
| EP0182442B1 (de) | 1990-07-11 |
| EP0182442B2 (de) | 1996-04-03 |
| KE3747A (en) | 1987-10-02 |
| NL930010I1 (nl) | 1993-04-01 |
| NL930010I2 (nl) | 1994-08-16 |
| EP0182442A3 (en) | 1986-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4503035B1 (en) | Protein purification process and product | |
| JPS57132895A (en) | Production of rearranged dna molecule and protein | |
| PT70495A (en) | Purified proteins and process therefor | |
| PT72322B (en) | Process for preparation of recombinant dna molecules and of polipeptides similar to human interferon | |
| DE3072134D1 (en) | Interferon proteins and method of producing same | |
| JPS5543488A (en) | Electrode assembly and method of producing same | |
| CY1580A (en) | Recombinant dna molecules and their method of production | |
| GB2063093B (en) | Process and column for gel filtration | |
| JPS5550892A (en) | Protein production * modified dna and vector applicable to said method | |
| JPS54157517A (en) | Method of manufacturing and using dialdehydeepolyol addition product | |
| MW3379A1 (en) | Purified proteins and process therefor | |
| JPS54141790A (en) | Modified dna and method of manufacturing hybrid protein using it | |
| JPS5494456A (en) | Claddmetal multipleemembered product and method of making same | |
| IL58721A0 (en) | Process for the production of prefabricated and the panels thereof | |
| GB2049700B (en) | Process of conservation of immobilized proteins | |
| JPS5510487A (en) | Method of making glass surface nonncoagulative and nonncoagulative glass product thereby | |
| JPS54163894A (en) | Production and utilizaton of llamino acid substituted polypeptide | |
| ZA796921B (en) | Recombinant dna molecules and their method of production | |
| GB2012099B (en) | Self-supporting electrode and method of making same | |
| JPS5592492A (en) | Multiilayer glass and production of same | |
| JPS54148263A (en) | Electrode material and method of producing same | |
| GB2028307B (en) | Production of pyrrolidin-2-ones and 3-pyrrolin-2-ones | |
| JPS5516166A (en) | Construction of heattinsulating material and method of making said material | |
| GB2103220B (en) | 27-desamidosecretin and production of same through recombinant dna technique | |
| JPS5498310A (en) | Production of dermatophytosis treating medicine |